Company Overview

Company name: Aphria (TSE: APHA)
Description: Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints of federal prohibition. It has some U.S. exposure through the acquisition of SweetWater, a craft brewery. The company is focusing on expanding through international cultivation and distribution into the global medical cannabis market. Aphria also offers multiple products under a portfolio of recreational cannabis brands, including B!NGO, Solei, RIFF, and Broken Coast.
Year founded: 2014
Parent company:
Industry: Healthcare | Group: | Code:
Website: www.aphria.com
Employees: 300
City: Leamington
State: Ontario
Country: Canada
Region:

Financial Highlights

Start up capital raised (USD Million):
Business status: Generating Revenue/Not Profitable
Ownership: Publicly Held
Exchange: TSE
Ticker: APHA
Revenue (USD Million): 416,64
Gross profit (USD Million): 163,29
Net income (USD Million) -78,86
Enterprise value: 1.361,45
Earnings before interest, tax, depreciation and amortization (EBITDA):
Fiscal period: TTM 1Q2021
Financing Status:
Number of active investors:
Profile last updated: 24-dic-2020
Last known valuation: 2.082,51
Last known valuation date: 30-dic-2018